Welcome to LookChem.com Sign In|Join Free
  • or
3-Thiomorpholinecarboxylic acid, 4-[(4-methylphenyl)sulfonyl]-, (3R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

220605-36-7

Post Buying Request

220605-36-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

220605-36-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 220605-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,6,0 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 220605-36:
(8*2)+(7*2)+(6*0)+(5*6)+(4*0)+(3*5)+(2*3)+(1*6)=87
87 % 10 = 7
So 220605-36-7 is a valid CAS Registry Number.

220605-36-7Relevant academic research and scientific papers

Thiazine amide derivative thereof in the preparation of medicaments for preventing neurodegenerative diseases, the use of the

-

Paragraph 0021; 0033-0034, (2017/02/23)

The invention relates to a compound shown as the formula I, pharmaceutically acceptable salts of the compound, and/ or solvates and/ or hydrates of the compound. The invention also relates to a preparation method of the compound, a medicinal composition c

THIAZINE AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

-

Paragraph 0046, (2015/07/15)

The present invention relates to a thiazine amide derivative and a pharmaceutical use thereof, and particularly to a compound of formula I (in the formula, variables are as described in the specification), a pharmaceutically acceptable salt, solvate or hy

Thiazine Amide Derivative and Pharmaceutical Composition and Use Thereof

-

Paragraph 0065, (2015/07/27)

The present invention relates to a thiazine amide derivative and a pharmaceutical use thereof, and particularly to a compound of formula I (in the formula, variables are as described in the specification), a pharmaceutically acceptable salt, solvate or hy

STEROID SPARING AGENTS AND METHODS OF USING SAME

-

Page/Page column 383; 399; 401, (2010/02/14)

This invention relates generally to the use of a steroid sparing agent for the preparation of a medicament for the treatment of inflammatory bowel diseases (IBD), asthma, multiple sclerosis (MS), rheumatoid arthritis (RA), graft versus host disease (GVHD), host versus graft disease, and various spondyloarthropathies, comprising administering a steroid sparing immunoglobulin or small molecule composition to a patient in need thereof. The invention also relates generally to combination therapies for the treatment of these conditions.

Substituted 6?membered n?heterocyclic compounds and their uses as neurological regulator

-

Page/Page column 6, (2008/06/13)

This invention relates to substituted 6-membered N-Herterocyclic neurotrophic compounds of formula (I) or pharmaceutically acceptable salts or hydrates thereof, wherein R1, R2, X, Y, and Z are as defined in the description; their pre

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 220605-36-7